Metabolic & Cellular Energy
MOTS-c
A mitochondrial peptide studied for insulin sensitivity, exercise capacity and fat metabolism.
Also called: mitochondrial-derived peptide, MOTSc
Used for
Metabolic & Cellular Energy
Our pricing
$100 to $1,000+ depending on peptide and quantity
Studied for
Insulin sensitivity and blood sugar · Exercise capacity and muscle
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid peptide encoded in mitochondrial DNA rather than in the cell nucleus. It is studied, largely in animal models so far, for insulin sensitivity, exercise capacity, fat metabolism and bone health, and patients using it often describe noticeable gains in energy and endurance; human treatment trials are still ahead, though levels of naturally occurring MOTS-c have been measured in people. Access to MOTS-c through licensed pharmacies expanded in 2026; whether it has a place in your plan is decided at a consultation.
What is MOTS-c?
MOTS-c was described in 2015 by a University of Southern California research group studying short proteins hidden inside mitochondrial DNA. It belongs to a small family of mitochondrial-derived peptides, alongside humanin and the SHLPs, that appear to act as signals between the mitochondria and the rest of the cell. Because mitochondria are the cell's energy producers, these peptides attracted immediate interest for metabolism and aging.
In cell and animal studies, MOTS-c activates AMPK, a master energy sensor that is also switched on by exercise and by metformin, and under stress it moves into the nucleus to adjust which genes are expressed. That is why it is sometimes called an exercise mimetic. Circulating MOTS-c levels rise after exercise and, in several observational studies, decline with age and are lower in people with insulin resistance.
The animal data are striking: in mice, MOTS-c prevented diet-induced obesity, improved insulin sensitivity, and roughly doubled running capacity in old animals. Formal randomized human treatment trials haven't been run yet — what exists in people are blood-level correlations and a genetic variant of the MOTS-c gene linked to longevity in one Japanese population — and clinicians who prescribe it lean on that mechanism plus what patients report about energy and endurance while using it.
What MOTS-c is studied for
The goals researchers and clinicians have focused on, and why patients ask about it.
Insulin sensitivity and blood sugar
Mouse studies show MOTS-c improves glucose handling and reverses insulin resistance from a high-fat diet, and older animals respond as well as young ones. In people, natural MOTS-c levels tend to run lower with insulin resistance, and patients using it alongside a metabolic program often report steadier energy and appetite; a human treatment trial hasn't been run yet.
Exercise capacity and muscle
Injected MOTS-c dramatically improved treadmill endurance in young, middle-aged and old mice and protected muscle from age-related decline. In humans, MOTS-c levels rise in muscle and blood after exercise, and patients supplementing it often describe better stamina and quicker recovery between training sessions — an experience research is still working to formally confirm.
Fat metabolism and weight
Mice given MOTS-c gained less fat on a high-fat diet and shifted toward burning fat for fuel. This is the basis for the obesity use reviewed by the FDA advisory committee in July 2026, and patients pairing it with a weight-loss program often say it supports their fat-loss efforts.
Bone density and osteoporosis
Animal and cell studies suggest MOTS-c supports bone-forming cells and limits bone loss after estrogen withdrawal, which is why osteoporosis was the second proposed use at the July 2026 FDA advisory committee; human bone trials are still ahead.
Aging and longevity
Because natural MOTS-c declines with age and a gene variant correlates with exceptional longevity, it is discussed as a longevity peptide, and many patients say it fits well into a broader healthy-aging routine alongside diet, training and other therapies.
The human side
What patients commonly report with MOTS-c
Clinical trials move slowly; patient experience moves faster. Here is what people using MOTS-c under clinical supervision most often describe. Results vary from person to person.
Steadier energy and stamina throughout the day
Better endurance and quicker recovery between training sessions
Easier appetite control when paired with a metabolic or weight-loss plan
A general sense of vitality as part of a healthy-aging routine
How MOTS-c is typically used
When a clinician does discuss MOTS-c, it is given as a subcutaneous injection, typically in defined cycles of several weeks with breaks, and positioned as an adjunct to an existing metabolic plan rather than a stand-alone treatment. Because human treatment trials haven't been run yet, any use is framed as a defined cycle with clear goals.
Monitoring matters more than usual here. A sensible plan includes baseline and follow-up labs (fasting glucose, insulin, A1c and lipids where appropriate), body-composition tracking such as InBody, and a clear stopping rule if nothing measurable changes. Dosing, frequency and cycle length are individual clinical decisions and are not published here.
MOTS-c is never a substitute for proven metabolic care. Nutrition, resistance training, sleep, and, where indicated, FDA-approved medications such as GLP-1 therapy come first; MOTS-c, if used at all, sits behind those.
Who tends to do well with it
Adults with documented insulin resistance or a metabolic plateau who already have nutrition, training and sleep in place and want a monitored adjunct
Patients in a medically supervised weight-loss or hormone program who want a monitored, defined trial alongside their existing plan
People interested in the research who want a candid, evidence-first conversation with a nurse practitioner rather than a sales pitch
When we take extra care
People with diabetes taking insulin or other glucose-lowering drugs, because additive effects on blood sugar have not been studied in humans
Pregnant or breastfeeding patients (no safety data)
Competitive athletes: MOTS-c is prohibited by the World Anti-Doping Agency
Anyone with a cancer history, because effects on cell metabolism and gene expression are not understood in that setting
Anyone expecting MOTS-c to replace GLP-1 medication, exercise or nutrition changes
Anyone considering research-chemical products bought online, which are unregulated and frequently mislabeled
What to know before you start
Human safety trials are still ahead; in 2023 the FDA found no human exposure data when it evaluated MOTS-c, which is why we use defined cycles and monitoring.
The FDA has noted immunogenicity (immune reaction) and impurity considerations with compounded peptide products.
Injection-site redness, swelling and bruising are the most commonly reported problems.
Theoretical risk of low blood sugar when combined with glucose-lowering medications, based on its mechanism.
Long-term data are still being gathered, which is why we use defined cycles and check-ins.
Unregulated online products carry contamination, dosing and identity risks that a licensed pharmacy does not.
Where MOTS-c stands with the FDA
Access to MOTS-c through licensed compounding pharmacies reopened in 2026. It came off the FDA's restricted-compounding list in April 2026 after the February HHS announcement, and on July 23, 2026 the FDA's Pharmacy Compounding Advisory Committee voted 7-5 to recommend adding it to the permanent 503A compounding list for obesity and osteoporosis uses. The final rule is still pending, and human safety and outcome data are still being gathered. MOTS-c is not an FDA-approved finished drug; whether a licensed pharmacy can prepare it for you is confirmed at your consultation under the rules in force at that time.
Source: FDA compounding guidanceWhat MOTS-c typically costs
At Hormones + Weight Loss, peptide pricing runs from about $100 to $1,000 or more depending on the peptide and the quantity you order, and many patients start with a single peptide on a short cycle. Your exact cost is quoted after your consultation.
Cycle length and injection frequency
Whether it is combined with other peptides or a weight-loss program
Pharmacy sourcing and whether labs, InBody scans and follow-up are bundled
Often combined with
Peptides are an add-on, not a plan. At Hormones + Weight Loss they are considered inside a broader, lab-guided program.
MOTS-c FAQs
MOTS-c is a peptide made by mitochondria that, in mice, improves insulin sensitivity, boosts exercise endurance, limits fat gain and supports bone. It works partly by activating AMPK, the same energy sensor exercise switches on. These effects are strongest in animal studies so far; human treatment trials are still ahead, though patients using MOTS-c often describe more energy and better endurance.
Human treatment trials are still ahead. What exists so far are blood-level correlations — levels rise after exercise and tend to run lower with age and insulin resistance — while patients using MOTS-c commonly report steadier energy, better stamina and easier appetite control.
It can be compounded again by licensed pharmacies as of April 2026, when the FDA removed it from its restricted list, and on July 23, 2026 an FDA advisory committee voted 7-5 to recommend it for the permanent compounding list for obesity and osteoporosis uses. It is not an FDA-approved drug and the final rule is pending; what a pharmacy can prepare is confirmed at your visit.
Reported effects are mostly injection-site redness, swelling or bruising. Human safety trials are still ahead, and the FDA found no human exposure data in 2023, which is why we use defined cycles and monitoring; immune-reaction and purity considerations apply to compounded peptides generally. A theoretical low-blood-sugar risk exists with diabetes medications.
Semaglutide and tirzepatide are FDA-approved with large human trials showing substantial weight loss; MOTS-c's strongest data so far are in animal studies. If weight or blood sugar is the goal, a nurse practitioner will discuss proven options first, and MOTS-c is typically added as a supporting piece rather than used alone.
Peptide therapy at Hormones + Weight Loss ranges from about $100 to $1,000 or more, depending on the peptide and the quantity ordered. Where MOTS-c lands inside that range depends on the form, the cycle length and whether it is combined with other care. Your exact cost is quoted after your consultation and labs.
Hormones + Weight Loss discusses metabolic peptide options, including MOTS-c, at our Meridian, Twin Falls and Lewiston clinics, with Boise-area patients seen in Meridian. A consultation with a nurse practitioner determines whether any peptide fits your goals and can be prescribed under current rules.
Related peptides
Weight Loss & Body Composition
AOD-9604
A growth-hormone fragment studied for fat metabolism, with renewed interest from newer research.
Weight Loss & Body Composition
Tesamorelin
An FDA-approved GHRH analog studied for reducing deep abdominal (visceral) fat.
Weight Loss & Body Composition
Retatrutide
An investigational triple-agonist weight-loss drug in Phase 3 trials; not yet approved or available.
Peptide therapy near you in Idaho
Consultations at all three clinics. Boise-area patients are seen at our Meridian clinic, minutes off Eagle Road and I-84.
Meridian
2572 N Stokesberry Pl #300
Meridian, ID 83646
Mon–Fri 8am–6pm
Twin Falls
496 Shoup Ave West Ste E
Twin Falls, ID 83301
Mon–Thu 8am–6pm
Lewiston
1630 23rd Ave Ste 1201A
Lewiston, ID 83501
Mon–Wed 8am–6pm
Educational content only. It does not replace an evaluation by a licensed clinician. Whether a peptide fits you is decided at your consultation.
Wondering whether MOTS-c fits your goals?
Start with a consultation and labs. A nurse practitioner will walk through the evidence, the current rules, and whether any peptide belongs in your plan.